Allan Bedwick is a 30+ year veteran of the Asian capital markets who spent the first two decades of his career at global investment banks including Merrill Lynch, Deutsche Bank, Greenwich NatWest and Lehman Brothers, where he built and managed proprietary trading desks focused on the pan-Asian markets. From 2009, Allan has launched two successful hedge funds with assets well over USD $1B and served as COO, head of risk and board member of three others.

Over the past 25 years, he has been an active investor in private companies with a primary focus on early-stage investments in high growth biotech and fintech opportunities in Asia and the US. He currently serves as an advisor to a number of early-stage ventures in Asia and Europe and has extensive governance experience in both private companies and funds/asset management. Allan received his BS in biology from University of Scranton and attended Thomas Jefferson Medical College.